LEAP THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) in USD for Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Leap Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for Q3 2024.
  • Leap Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $708K.
  • Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $147K.
  • Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$24K, a 1100% decline from 2020.
  • Leap Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2K, a 33.3% increase from 2019.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $708K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.